Kalbe Farma Tbk PT
IDX:KLBF
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 400
1 750
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Kalbe Farma Tbk PT
Kalbe Farma Tbk PT
Total Current Liabilities
Kalbe Farma Tbk PT
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Total Current Liabilities
Rp4.3T
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Total Current Liabilities
Rp2.8T
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Total Current Liabilities
Rp610.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Total Current Liabilities
Rp2.2T
|
CAGR 3-Years
7%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Total Current Liabilities
Rp2.3T
|
CAGR 3-Years
172%
|
CAGR 5-Years
141%
|
CAGR 10-Years
49%
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Total Current Liabilities
Rp7.8T
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
24%
|
|
Kalbe Farma Tbk PT
Glance View
PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 12,334 full-time employees. The firm provides healthcare solution through its four business divisions: the prescription pharmaceutical division, consumer health, nutritional, and distribution and logistics divisions. Its Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. Its Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.
See Also
What is Kalbe Farma Tbk PT's Total Current Liabilities?
Total Current Liabilities
4.3T
IDR
Based on the financial report for Jun 30, 2024, Kalbe Farma Tbk PT's Total Current Liabilities amounts to 4.3T IDR.
What is Kalbe Farma Tbk PT's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
2%
Over the last year, the Total Current Liabilities growth was -15%. The average annual Total Current Liabilities growth rates for Kalbe Farma Tbk PT have been 11% over the past three years , 10% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
